SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-031433
Filing Date
2022-09-12
Accepted
2022-09-12 08:45:17
Documents
15
Period of Report
2022-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR FINANCING adpt-8k_20220912.htm   iXBRL 8-K 53388
2 EX-10.1 adpt-ex101_62.htm EX-10.1 728477
3 EX-99.1 PRESS RELEASE adpt-ex991_47.htm EX-99.1 13887
4 GRAPHIC geq3q1aivrp3000001.jpg GRAPHIC 32591
  Complete submission text file 0001564590-22-031433.txt   1089707

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA adpt-20220912.xsd EX-101.SCH 5617
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20220912_lab.xml EX-101.LAB 18574
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20220912_pre.xml EX-101.PRE 11056
9 EXTRACTED XBRL INSTANCE DOCUMENT adpt-8k_20220912_htm.xml XML 3434
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 221237603
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences